Previous Article | Next Article 
Journal of Clinical Microbiology, September 2008, p. 3136-3138, Vol. 46, No. 9
0095-1137/08/$08.00+0 doi:10.1128/JCM.00478-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Evaluation of Four Selective Agars and Two Enrichment Broths in Screening for Methicillin-Resistant Staphylococcus aureus
S. Böcher,1*
R. Smyth,2
G. Kahlmeter,2
J. Kerremans,3
M. C. Vos,3 and
R. Skov1
National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark,1
The Swedish External Reference Centre for Antimicrobial Susceptibility Testing, Central Hospital, Växjö, Sweden,2
Department of Medical Microbiology and Infectious Diseases, Erasmus University Center, Rotterdam, The Netherlands3
Received 11 March 2008/
Returned for modification 2 May 2008/
Accepted 7 July 2008

ABSTRACT
To evaluate methicillin-resistant
Staphylococcus aureus detection,
we tested in vitro four selective agars and two enrichment broths
apart and in combination. Tryptone soya broth with salt, aztreonam,
and cefoxitin appeared to be the most sensitive medium. This
broth was superior to a phenol red mannitol broth with aztreonam
and ceftizoxime.

TEXT
Methicillin-resistant
Staphylococcus aureus (MRSA) is a major
cause of morbidity and mortality worldwide. Detection of MRSA
in screening samples is an important part of the control of
MRSA, but due to annex flora, the low level of MRSA often found
in screening samples, and the emergence of heteroresistant MRSA
strains (
4,
8,
9,
12), this is laborious and often difficult.
Further cocolonization with other staphylococcal species might
lead to false-positive results, especially when using PCR-based
methods (
1). The use of an enrichment broth for MRSA detection
is known to increase sensitivity but requires an extra day of
incubation (
13,
14,
16). Several brands of chromogenic agars
supplemented with antibiotics have recently become available
and have performed well by direct inoculation and 24-h incubation
(
2,
13,
14). However, studies that compare chromogenic agars
show conflicting results (
2). Most of the published evaluations
were performed on samples with the traditional "health care-associated"
MRSA strains and with no information on the clonal diversity
of the investigated isolates. Clonal differences are known to
be one of the reasons for discrepancies when MRSA selective
media are studied (
7).
We evaluated the performance in vitro of four different selective agars and two enrichment broths, separately and in combination, using low inocula of MRSA isolates.
Ninety-six well-characterized MRSA strains, representing 13 clonal complexes and all six main SCCmec types (6), including low-level-resistant isolates; 52 methicillin-sensitive Staphylococcus aureus (MSSA) isolates; and 49 methicillin-resistant coagulase-negative staphylococcus (MRCNS) isolates were tested. The agars tested were ChromID MRSA (bioMérieux, Marcy l'Etoile, France); MRSA Select (Bio-Rad, Hercules, CA); a chromagar plate manufactured at Statens Serum Institut (SSI) on license from CHROMagar, Paris, France (MRSA SSI); a mannitol salt agar with 4 mg/liter cefoxitin (MSA); and a 5% blood agar (BA). Two enrichment broths were tested, (i) phenol red mannitol broth with 0.5% salt, 75 mg/liter aztreonam, and 5 mg/liter ceftizoxime (PHMB) (16) and (ii) tryptone soya broth with 2.5% salt, 20 mg/liter aztreonam, and 3.5 mg/liter cefoxitin (TSB) from SSI. The concentrations included in TSB were based on pilot investigations (data not shown). These tests showed that 3 mg/liter cefoxitin allowed breakthrough growth of MSSA and that 4 mg/liter cefoxitin and >20 mg/liter aztreonam resulted in loss of sensitivity. Approximately 20 CFU (20 µl of 103 CFU/ml vortexed suspension in 0.9% NaCl) of each strain taken from the same suspension, made from fresh overnight-incubated isolates, were inoculated directly onto agar plates and into the two broths. After 18 to 20 h and 40 to 48 h of incubation at 35°C (±1°C), colony color and counts were registered for each of the agar plates. For broths, turbidity and color change were registered after 18 to 20 h of incubation, followed by subculturing 20 µl of the broth suspension onto each of the agar plates. Plates were incubated at 35°C (±1°C) for another 18 to 24 h. Colony counts were read semiquantitatively. Specificity was defined as the percentage of plates without growth of MSSA and MRCNS exhibiting the same colony color as the MRSA isolates. MICs for MRSA isolates were determined using an Etest (AB Biodisk, Solna, Sweden) on Mueller-Hinton agar with 2% NaCl as described by the manufacturer.
The performance of the plates, with and without enrichment, is shown in Table 1.
No difference was seen between the chromogenic agars irrespective
of enrichment and enrichment broth. Optimal sensitivity was
obtained after 18 to 24 h of incubation. Forty-eight hours of
incubation only caused additional growth of MSSA and MRCNS,
leading to reduced specificity.
The mannitol salt agar with cefoxitin required either 48 h of incubation or prior enrichment in TSB to achieve comparable sensitivity.
Preincubation in PHMB resulted in a lower sensitivity on all plates (Table 1), whereas TSB did not reduce the sensitivity of the chromogenic agars and increased the sensitivity of the MSA plate. Preincubation in either of the two broths resulted in breakthrough growth of MSSA. Table 2 shows the numbers of isolates with no growth or reduced growth (<1,000 colonies) on the individual chromogenic agars and on the blood agar plate after incubation in the two enrichment broths.
View this table:
[in this window]
[in a new window]
|
TABLE 2. Distribution of strains with reduced growth (RG) or no growth (NG) on the chromogenic MRSA selective media and on BA after incubation in enrichment brothsb
|
To confirm the observed differences between the two broths,
43 MRSA strains, including the 24 MRSA strains which did not
grow in PHMB at SSI, were blinded and sent to Erasmus University
Center (EUC) for a second evaluation. Six of the isolates did
not grow after incubation in PHMB (Table
2). In addition, 3
of the remaining 37 isolates produced <1,000 colonies when
plated after enrichment. All isolates grew well in TSB. Using
a best-case scenario for PHMB (growth in at least one of the
two experiments), a sensitivity of only 93% was found for preenrichment
in PHMB, compared to a sensitivity of 100% for TSB. The observed
difference in sensitivity between the two evaluations (76% versus
94%) for PHMB could be due to a slightly higher inoculum in
the second evaluation, as indicated by colony counts. The median
inoculum in the first evaluation was 21 CFU (range of 10 to
42 CFU), and that in the second evaluation was 27 CFU (range
of 9 to 100 CFU).
Our in vitro evaluation showed that three chromogenic MRSA agars all supported the growth of this diverse collection of MRSA strains at low inocula. Specificity was high, provided that a maximum of 24 h of incubation was used (Table 1). The PHMB enrichment displayed low sensitivity, suggesting that the antibiotic concentration was too high. TSB supported growth of all of the MRSA strains tested. Incubation of the chromogenic agars beyond 24 h led to increased breakthrough growth of MSSA isolates. The MSA plate showed sensitivity comparable to that of the chromogenic agars only after preenrichment.
Although our in vitro results implied that the chromogenic agars did not perform better when preceded by enrichment, two recent studies of clinical specimens both showed that an enrichment step in combination with chromogenic agars led to increased sensitivities of 14 to 26% and 12%, respectively (10, 15). These studies indicate that, under clinical conditions, sensitivity is significantly increased by the addition of an enrichment step even when chromogenic agars are used.
Our study shows that TSB with low-level cefoxitin and aztreonam is a better alternative than PHMB, as published by Wertheim et al. (16). Furthermore, TSB works well with a PCR-based method for MRSA detection (11).
Although more studies on the use of chromogenic media with and without enrichment are needed to clarify the best practice, it now seems quite clear that when designing enrichment broths one has to be careful with salt content and antibiotic concentrations, since either may inhibit the growth of some MRSA isolates (3, 5, 15).
In conclusion, delineation of the optimal phenotypic method is still important for epidemiological reasons like strain typing and resistance testing. Even in the new era of rapid molecular techniques, an enrichment step may still be advantageous.

FOOTNOTES
* Corresponding author. Mailing address: Statens Serum Institut, National Center for Antimicrobials and Infection Control, Artillerivej 5 (B.47/213), DK-2300 Copenhagen S, Denmark. Phone: 45 3268 3684. Fax: 45 3268 3231. E-mail:
sbc{at}ssi.dk 
Published ahead of print on 16 July 2008. 

REFERENCES
1 - Becker, K., I. Pagnier, B. Schuhen, F. Wenzelburger, A. W. Friedrich, F. Kipp, G. Peters, and C. von Eiff. 2006. Does nasal cocolonization by methicillin-resistant coagulase-negative staphylococci and methicillin-susceptible Staphylococcus aureus strains occur frequently enough to represent a risk of false-positive methicillin-resistant S. aureus determinations by molecular methods? J. Clin. Microbiol. 44:229-231.[Abstract/Free Full Text]
2 - Brown, D. F., D. I. Edwards, P. M. Hawkey, D. Morrison, G. L. Ridgway, K. J. Towner, and M. W. Wren. 2005. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J. Antimicrob. Chemother. 56:1000-1018.[Abstract/Free Full Text]
3 - Bruins, M. J., P. Juffer, M. J. Wolfhagen, and G. J. Ruijs. 2007. Salt tolerance of methicillin-resistant and methicillin-susceptible Staphylococcus aureus. J. Clin. Microbiol. 45:682-683.[Free Full Text]
4 - Hartman, B. J., and A. Tomasz. 1986. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 29:85-92.[Abstract/Free Full Text]
5 - Jones, E. M., K. E. Bowker, R. Cooke, R. J. Marshall, D. S. Reeves, and A. P. MacGowan. 1997. Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J. Hosp. Infect. 35:59-62.[CrossRef][Medline]
6 - Kondo, Y., T. Ito, X. X. Ma, S. Watanabe, B. N. Kreiswirth, J. Etienne, and K. Hiramatsu. 2007. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob. Agents Chemother. 51:264-274.[Abstract/Free Full Text]
7 - Merlino, J., M. Leroi, R. Bradbury, D. Veal, and C. Harbour. 2000. New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J. Clin. Microbiol. 38:2378-2380.[Abstract/Free Full Text]
8 - Merlino, J., J. Watson, B. Rose, M. Beard-Pegler, T. Gottlieb, R. Bradbury, and C. Harbour. 2002. Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in central Sydney, Australia. J. Antimicrob. Chemother. 49:793-801.[Abstract/Free Full Text]
9 - Mir, N., M. Sanchez, F. Baquero, B. Lopez, C. Calderon, and R. Canton. 1998. Soft salt-mannitol agar-cloxacillin test: a highly specific bedside screening test for detection of colonization with methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 36:986-989.[Abstract/Free Full Text]
10 - Nahimana, I., P. Francioli, and D. S. Blanc. 2006. Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 12:1168-1174.[CrossRef][Medline]
11 - Ornskov, D., B. Kolmos, H. P. Bendix, N. J. Nederby, I. Brandslund, and P. Schouenborg. 2008. Screening for methicillin-resistant Staphylococcus aureus in clinical swabs using a high-throughput real-time PCR-based method. Clin. Microbiol. Infect. 14:22-28.[Medline]
12 - Rohr, U., C. Mueller, M. Wilhelm, G. Muhr, and S. Gatermann. 2003. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. J. Hosp. Infect. 54:305-309.[CrossRef][Medline]
13 - Safdar, N., L. Narans, B. Gordon, and D. G. Maki. 2003. Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: a prospective study comparing 32 methods. J. Clin. Microbiol. 41:3163-3166.[Abstract/Free Full Text]
14 - Stoakes, L., R. Reyes, J. Daniel, G. Lennox, M. A. John, R. Lannigan, and Z. Hussain. 2006. Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44:637-639.[Abstract/Free Full Text]
15 - van Loo, I., S. van Dijk, I. Verbakel-Schelle, and A. G. Buiting. 2007. Evaluation of a chromogenic agar (MRSASelect) for the detection of methicillin-resistant Staphylococcus aureus with clinical samples in The Netherlands. J. Med. Microbiol. 56:491-494.[Abstract/Free Full Text]
16 - Wertheim, H., H. A. Verbrugh, C. van Pelt, P. de Man, A. van Belkum, and M. C. Vos. 2001. Improved detection of methicillin-resistant Staphylococcus aureus using phenyl mannitol broth containing aztreonam and ceftizoxime. J. Clin. Microbiol. 39:2660-2662.[Abstract/Free Full Text]
Journal of Clinical Microbiology, September 2008, p. 3136-3138, Vol. 46, No. 9
0095-1137/08/$08.00+0 doi:10.1128/JCM.00478-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Van Heirstraeten, L., Abrahantes, J. C., Lammens, C., Lee, A., Harbarth, S., Molenberghs, G., Aerts, M., Goossens, H., Malhotra-Kumar, S., on behalf of the MOSAR WP2 Study Group,
(2009). Impact of a Short Period of Pre-Enrichment on Detection and Bacterial Loads of Methicillin-Resistant Staphylococcus aureus from Screening Specimens. J. Clin. Microbiol.
47: 3326-3328
[Abstract]
[Full Text]